Bulut Yurtsever
Overview
Explore the profile of Bulut Yurtsever including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tumentemur G, Aygun E, Yurtsever B, Cakirsoy D, Ovali E
J Dermatolog Treat
. 2025 Jan;
36(1):2451389.
PMID: 39827901
Human amniotic fluid stem cells (hAFSCs) have shown significant regenerative potential in treating hair loss, wound healing, and tissue repair. This study aims to evaluate the effects of human amniotic...
2.
Hemsinlioglu C, Aslan E, Tastan C, Cakirsoy D, Turan R, Seyis U, et al.
Turk J Haematol
. 2023 Apr;
40(2):118-124.
PMID: 37022209
Objective: Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency of plasma coagulation factor VIII (FVIII), and it accounts for about 80%-85% of all cases of hemophilia....
3.
Arisan E, Dart D, Grant G, Dalby A, Kancagi D, Turan R, et al.
ACS Omega
. 2022 Oct;
7(42):38003-38014.
PMID: 36275122
microRNAs (miRs) are proposed as critical molecular targets in SARS-CoV-2 infection. Our recent studies identified seven SARS-CoV-2 specific miR-like sequences, which are highly conserved with humans, including miR-1307-3p, with critical...
4.
Erdogan E, Yalcin K, Hemsinlioglu C, Sezgin A, Seyis U, Kancagi D, et al.
Turk J Haematol
. 2022 Jul;
39(3):206-210.
PMID: 35848614
Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial...
5.
Ng O, Akyoney S, Sahin I, Soykam H, Akcapinar G, Ozdemir O, et al.
PLoS One
. 2021 Dec;
16(12):e0260438.
PMID: 34871297
The Coronavirus Disease 2019 (COVID-19) was declared a pandemic in March 2020 by the World Health Organization (WHO). As of May 25th, 2021 there were 2.059.941 SARS-COV2 genome sequences that...
6.
Turan R, Tastan C, Kancagi D, Yurtsever B, Sir Karakus G, Ozer S, et al.
Sci Rep
. 2021 Aug;
11(1):15799.
PMID: 34349145
The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and...
7.
Sir Karakus G, Tastan C, Kancagi D, Yurtsever B, Tumentemur G, Demir S, et al.
Sci Rep
. 2021 Mar;
11(1):5804.
PMID: 33707532
COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality....
8.
Tastan C, Kancagi D, Turan R, Yurtsever B, Cakirsoy D, Abanuz S, et al.
Turk J Haematol
. 2020 Aug;
37(4):234-247.
PMID: 32755128
Objective: Relapsed and refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) are the focus of studies on hematological cancers. Treatment of these malignancies has undergone recent transformation...
9.
Tastan C, Yurtsever B, Sir Karakus G, Kancagi D, Demir S, Abanuz S, et al.
Turk J Biol
. 2020 Jun;
44(3):192-202.
PMID: 32595356
The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA...